-
Mashup Score: 3Temferon Linked to Long-Term Survival in Some With Glioblastoma - 7 hour(s) ago
Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized after initial progression.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Is There a New Standard Way to Treat Advanced-Stage Melanoma? - 11 hour(s) ago
Ongoing research within the advanced-stage melanoma therapeutic space is beginning to suggest that shorter treatment periods may be sufficient for some.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Is There a New Standard Way to Treat Advanced-Stage Melanoma? @uw_medicine #Oncology #MedTwitter #Melanoma https://t.co/RkWGGrSadS
-
-
Mashup Score: 1Embracing Your ‘New Normal’ After a Cancer Diagnosis - 11 hour(s) ago
Valarie Traynham sat down for an interview in CURE in which she discussed adjusting to life after cancer, detailing her ‘new normal.’
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Embracing Your ‘New Normal’ After a Cancer Diagnosis #Oncology #BreastCancer #MedTwitter https://t.co/WbrR5Mr0Sn
-
-
Mashup Score: 2The Emotional Impact of Insurance Delays For Those With Cancer - 12 hour(s) ago
Dr. Alexandra Zaleta discussed the impact of administrative delays and insurance red tape experienced by patients with advanced cancer.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
The Emotional Impact of Insurance Delays For Those With Cancer @CancerCare #Oncology #MedTwitter https://t.co/IJBhblh347
-
-
Mashup Score: 0Dealing With the Unpredictability of Cancer - 12 hour(s) ago
My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and downs.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Dealing With the Unpredictability of Cancer #Oncology #BreastCancer #MedTwitter https://t.co/MXMxoH2zBH
-
-
Mashup Score: 1Bria-IMT Combo Shows Survival in Phase 2 Breast Cancer Trial - 12 hour(s) ago
In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Bria-IMT Combo Shows Survival in Phase 2 Breast Cancer Trial @dradityabardia @PittDeptofMed @UCLAHealth #Oncology #CancerCare #MedTwitter https://t.co/FtLLNeTotn
-
-
Mashup Score: 1Screening, Prehab May Reduce Breast Cancer Survivorship Burden - 12 hour(s) ago
Prehabilitation and early screening, including BIS, can ease recovery, reduce side effects and help manage lymphedema after breast cancer treatment.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Screening, Prehab May Reduce Breast Cancer Survivorship Burden #Oncology #BreastCancer #MedTwitter https://t.co/sTwg8p5rPa
-
-
Mashup Score: 2Leukemia's Lionheart: The Fight of a Lifetime - 12 hour(s) ago
A survivor shares the story of his experience with chronic myeloid leukemia.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
RT @MelDMann: Leukemia's Lionheart: The Fight of a Lifetime https://t.co/pYeHBPLrWl via @cure_today
-
-
Mashup Score: 5FDA Approves SIR-Spheres for Liver Cancer Treatment - 1 day(s) ago
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in the U.S. for both HCC and mCRC.
Source: www.curetoday.comCategories: General Medicine NewsTweet-
FDA Approves SIR-Spheres for Liver Cancer Treatment https://t.co/Qiu6KNHC7l
-
-
Mashup Score: 9
Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic breast cancer should know.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic #BreastCancer should know. @stolaney1 @DanaFarber https://t.co/ekQIpG6ybP
-
Temferon Linked to Long-Term Survival in Some With Glioblastoma #BrainCancer #MedTwitter https://t.co/DU5NcpVBlw